Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Department of Neurosurgery, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Pituitary. 2023 Jun;26(3):288-292. doi: 10.1007/s11102-023-01304-9. Epub 2023 Mar 27.
Accurate localization of the site(s) of active disease is key to informing decision-making in the management of refractory pituitary adenomas when autonomous hormone secretion and/or continued tumor growth challenge conventional therapeutic approaches. In this context, the use of non-standard MR sequences, alternative post-acquisition image processing, or molecular (functional) imaging may provide valuable additional information to inform patient management.
准确定位活性疾病部位是决定治疗难治性垂体腺瘤时的关键，此时自主激素分泌和/或肿瘤持续生长挑战了常规治疗方法。在这种情况下，使用非标准磁共振序列、替代的采集后图像处理或分子（功能）成像可能会提供有价值的额外信息，以指导患者管理。
